Effects of Rituximab on the Progression of Type 1 Diabetes in New Onset Subjects

This study has been completed.
Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Type 1 Diabetes Mellitus
2		Additional conditions recognized in this trial
			Diabetes Mellitus
			Diabetes Mellitus, Type 1
3		More general conditions related to this trial
			Autoimmune Diseases
			Endocrine System Diseases
			Glucose Metabolism Disorders
			Immune System Diseases
			Metabolic Diseases
4		Interventions listed in this trial
			Anti-CD20 (rituximab)
5		Additional drug interventions recognized in this trial
			Rituximab
6		More general drug interventions related to this trial
			Antineoplastic Agents
			Antirheumatic Agents
			Immunologic Factors
			Pharmacologic Actions
			Physiological Effects of Drugs
			Therapeutic Uses
7		Sponsors listed in this trial
			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
			National Institute of Allergy and Infectious Diseases (NIAID)
			National Institute of Child Health and Human Development (NICHD)
			American Diabetes Association
			Juvenile Diabetes Research Foundation